Do new Alzheimer’s treatments really work? Once called a breakthrough, now being questioned for their impact on memory and daily life
New Alzheimer's drugs targeting brain amyloid show minimal real-world benefits, a major review found. While plaque reduction occurs, memory and daily function improvements are too small for most patients to notice. These treatments carry risks like brain swelling and require significant medical commitment, prompting a call for realistic expectations and broader dementia care strategies.
New Alzheimer's drugs targeting brain amyloid show minimal real-world benefits, a major review found. While plaque reduction occurs, memory and daily function improvements are too small for most patients to notice. These treatments carry risks like brain swelling and require significant medical commitment, prompting a call for realistic expectations and broader dementia care strategies.
